Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals
First in-person Goalkeepers event since 2019 convenes global changemakers to highlight the urgency of achieving a more equitable world by 2030 NEW YORK, Sept. 22, 2022 /PRNewswire/ -- During United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanthropies, the private sector, NGOs, and global and community leaders—announced commitments totalling $1.27 billion to improve and save...
Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug’s Best-in-Class Potential
SUZHOU, China and ROCKVILLE, Md., Sept. 21, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that the results from a Phase I and Phase II study of olverembatinib (HQP1351) for the treatment of chronic myeloid leukemia...
Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022
Lunit participates in the 20th Asian Oceanian Congress of Radiology and 78th Annual Meeting of the Korean Society of Radiology (AOCR & KCR 2022) Lunit's demonstration focuses on how radiologists and AI solutions can create synergy through combined workflows Visitors invited to Lunit Demo Station to partake in private meetings and product demonstrations SEOUL, South Korea, Sept....
Siyi Intelligence Successfully Exhibited Syrebo Rehabilitation Products at REHACARE 2022
DUSSELDORF, Germany, Sept. 21, 2022 /PRNewswire/ -- From September 14 to 17, one of the world's leading trade fairs for rehabilitation and care, REHACARE 2022, was held in Düsseldorf, Germany. A great deal of rehabilitation experts, therapists and TOP companies in the industry gathered together to showcase the latest innovative solutions for rehabilitation. Siyi Intelligence with its Syrebo Rehabilitation...
United Imaging and Carrollton Regional Medical Center Accelerate Installation of the Revolutionary uCT® ATLAS Scanner
Highlights Agility of Both Organizations in Responding to Patient Needs HOUSTON, Sept. 21, 2022 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that it delivered its flagship uCT ATLAS scanner earlier than first scheduled, at the request of Carrollton Regional Medical Center (CRMC). CRMC had placed the order for the...
Heads of State Commit to Noncommunicable Disease Global Compact to Save 50 Million Lives by 2030
Michael R. Bloomberg reappointed as WHO Global Ambassador for Noncommunicable Diseases and Injuries New Gallup survey indicates strong global support for policies outlined in WHO report to combat growing public health burden of noncommunicable diseases GENEVA and NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Today, Dr. Tedros Adhanom Ghebreyesus, Director-General...
Charsire’s New Drug Aims to Capture Multi-Billion-Dollar Dementia Treatment Market
TAINAN CITY, Taiwan, Sept. 21, 2022 /PRNewswire/ -- Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease and vascular dementia using its patented technology of Multi-Glycan Complex and soybeans as raw materials. BAC has completed Phase II clinical trial of the FDA. Dementia drugs in high demand...
Far Eastern New Century won the “Sustainability & Innovation Award” from ITMF Awards 2022 with FENC® TOPGREEN® Bio3
FENC® TOPGREEN® Bio3, World No.1 Fabric made from waste gas reuse technology & N66 solution dye. TAIPEI, Sept. 21, 2022 /PRNewswire/ -- As the pioneer in innovation and sustainability, Far Eastern New Century Corporation (FENC) is able to provide solutions to lower the environmental impact for both Poly and Nylon and our effort,...
Ivory Dentin Graft(TM), the First and Only Dentin Graft, Receives CE Mark
Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects. KEFAR SAVA, Israel, Sept. 21, 2022 /PRNewswire/ -- Developed by Ivory Graft Ltd., the Ivory Dentin Graft™ is a new dentin graft. This graft material has been tailored for use in dental procedures...
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19
LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Long COVID patients with a new herbal inspired medicine. According to...
